M4MM

Trulieve Reports Q3 2025 Financial Results

TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations ...

Jushi Holdings Reports Q3 2025 Financial Results

LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...

Starmer Rules Out Cannabis Legalization in UK

LIVERPOOL – British Prime Minister Keir Starmer made clear during a question-and-answer session with high school students this week that his government has no plans to legalize Cannabis, a position that stands in contrast to ...

Trulieve Reports Q3 2025 Financial Results

TALLAHASSEE – Trulieve Cannabis Corp. disclosed third-quarter results showing revenue of $288 million, edging up 1% from the year-ago period but dipping 5% from the second quarter. The figures highlight a push toward tighter operations ...

Jushi Holdings Reports Q3 2025 Financial Results

LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...

Green Thumb Industries Reports Strong Q2 2024 Performance

LOS ANGELES- Green Thumb Industries Inc. a Chicago-based cannabis company, posted solid second-quarter results for 2024, with revenue climbing 11% year-over-year to $280 million, exceeding analyst forecasts of $277.36 million. The company’s net income rose ...

atai Life Sciences Reports Q2 2024 Financial Results

LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant ...

Willow Biosciences Posts Record Revenue in Q2

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...

Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Criticism Mounts Over New York’s Social Equity Cannabis Fund for High Costs and Limited Impact; Arizona to Launch Recreational Cannabis Home Delivery; DeSantis Uses Opioid Settlement Funds for Anti-Cannabis Ads Ahead of Ballot Initiative

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Subscribe To Our Newsletter